3.14 Biotechnology is a startup that aims to carry out research and development activities on neurological and genetic diseases.
Our aim is to carry out research and development projects for treatments that can prevent genetic diseases that are difficult or impossible to treat yet. We are happy to see volunteers and professionals who want to support us. Although we are an idea that emerged in the first days of 2023, we believe that we will achieve good results and progress thanks to advances in technology and by coming together with the right scientists. We welcome you to contact us.
Company Details
- Founded
- -
- Address
- Heidelberg, De
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- Heidelberg
- Competitors
- VivaCell Biotechnology GmbH - Member of 1Q Health, CeBiTec - Center for Biotechnology (Bielefeld University), Goethe Biotechnology GmbH, FiZ Frankfurt Biotechnology Innovation Center, Anbio Biotechnology, Genekam Biotechnology AG, BioNTech SE, Yokogawa Insilico Biotechnology GmbH, Institute of Biotechnology at RWTH Aachen, KH Biotechnology UG (haftungsbeschränkt).
Biotechnology 3.14 Questions
Biotechnology 3.14's LinkedIn profile is https://de.linkedin.com/company/biotechnology-3-14
Biotechnology 3.14's industry is
Biotechnology Research
Biotechnology 3.14's top competitors are
Vivacell Biotechnology Gmbh - Member Of 1q Health,
Cebitec - Center For Biotechnology (Bielefeld University),
Goethe Biotechnology Gmbh,
Fiz Frankfurt Biotechnology Innovation Center,
Anbio Biotechnology,
Genekam Biotechnology Ag,
Biontech Se,
Yokogawa Insilico Biotechnology Gmbh,
Institute Of Biotechnology At Rwth Aachen,
Kh Biotechnology Ug (Haftungsbeschränkt).
Biotechnology 3.14's categories are Biotechnology Research
Biotechnology 3.14's founding year is 2023
